DekaBank Deutsche Girozentrale
ELDN icon

DekaBank Deutsche Girozentrale’s Eledon Pharmaceuticals ELDN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65
Closed -$56K – 1009
2016
Q1 		$56K Buy
+65
New +$63.8K ﹤0.01% 1017

Other funds holding ELDN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ELDN Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Eledon Pharmaceuticals (ELDN) in Q2 2016, closing a stake of 65 shares — an estimated $56K sold.

DekaBank Deutsche Girozentrale first reported a position in ELDN in Q1 2016 and held it in 1 quarter. The position peaked at $56K in Q1 2016. 48 funds tracked by Wall St. Rank hold ELDN as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Eledon Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 65 Eledon Pharmaceuticals shares in Q2 2016, an estimated $56K.
  • DekaBank Deutsche Girozentrale first reported a position in Eledon Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Eledon Pharmaceuticals position peaked at $56K in Q1 2016.
  • 48 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.